Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The surviving fraction was calculated as the ratio of the number of counted colonies to the number of seeded cells
Features: 20 mg Lipo-C + B-12 formulation Sterile 10 mL multi-dose research vial Utilized in research involving lipid metabolism , methylation , and vitamin B12-associated pathways Quality-controlled manufacturing Securely sealed for product integrity Suitable for laboratory and analytical research Clearly labeled for Research Use Only (RUO) Research Use Only (RUO)
& Muoz-Espn, D
Therapy duration varies from acute correction in metabolic crises to lifelong supplementation in primary systemic deficiency
Proof-of-principle evidence was provided that FXR1 antagonism could alleviate bone metastasis of ER+ breast cancer cells with acquired anti-estrogen resistance, wherein PI3K/AKT/mTOR signaling is often abnormally activated ( Statements Data availability statement The datasets presented in this study can be found in online repositories
US$ 28.47
US$ 20.37
US$ 21.31
US$ 21.47
US$ 23.15
